U.S. Markets closed

AstraZeneca PLC (AZN)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
33.85-0.49 (-1.43%)
At close: 4:02PM EDT
People also watch
GSKNVSSNYLLYBMY
Interactive chart
Previous Close34.34
Open34.13
Bid33.80 x 10000
Ask34.05 x 3000
Day's Range33.81 - 34.19
52 Week Range25.55 - 35.04
Volume2,555,256
Avg. Volume4,303,253
Market Cap83.43B
Beta0.67
PE Ratio (TTM)25.36
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.90 (5.53%)
Ex-Dividend Date2017-02-15
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journalsyesterday

    AstraZeneca recalls physician sample bottles of heart drug

    AstraZeneca is voluntarily recalling one lot of physician sample bottles of Brilinta — a blood-thinning drug prescribed to prevent stroke, heart attack and other heart problems — as a precautionary measure. The London-based pharmaceutical company, which has its U.S. headquarters in Wilmington, said the voluntary recall follows a report that a professional sample bottle containing eight, 90 milligram tablets of Brilinta also contained another medicine, Zurampic tablets, also manufactured by AstraZeneca (AZN).

  • Market Realist3 days ago

    Performance of Merck’s Diabetes Portfolio in 1Q17

    Combined sales for Januvia and Janumet were ~$1.3 billion for 1Q17, a ~5.0% fall from $1.4 billion in 1Q16.

  • AstraZeneca's Bydureon Fails to Reduce Cardiovascular Risk
    Zacks3 days ago

    AstraZeneca's Bydureon Fails to Reduce Cardiovascular Risk

    AstraZeneca plc (AZN) announced top-line results from the EXSCEL study evaluating the cardiovascular (CV) safety profile of its type II diabetes drug Bydureon.